Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants

Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants

Major depressive disorder (MDD) is a chronic relapsing psychiatric disorder. Conventional antidepressants usually require several weeks of continuous administration to exert clinically significant therapeutic effects, while about two-thirds of the patients are prone to relapse of symptoms or are com...

Full description

Bibliographic Details
Main Authors: Tao Chen, Ling Cheng, Jingwen Ma, Jiyuan Yuan, Chao Pi, Linjin Xiong, Jinglin Chen, Huiyang Liu, Jia Tang, Yueting Zhong, Xiaomei Zhang, Zerong Liu, Ying Zuo, Hongping Shen, Yumeng Wei, Ling Zhao
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Pharmacological Research
Subjects:
Depression
Rapid-acting antidepressant
Ketamine
Hallucinogens
Adenosine A1 receptors
Glutamate
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661823001937

Internet

http://www.sciencedirect.com/science/article/pii/S1043661823001937

Similar Items